The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
Abstract
Hormone refractory metastatic prostate cancer remains an incurable disease. We found that high expression levels of the chemokine receptor CXCR4 correlated with the presence of metastatic disease in prostate cancer patients. Positive staining for CXCL12, the ligand for CXCR4, was mainly present in the tumor‐associated blood vessels and basal cell hyperplasia. Subcutaneous xenografts of PC3 and 22Rv1 prostate tumors that overexpressed CXCR4 in NOD/SCID mice were two‐ to threefold larger in volume and weight vs. controls. Moreover, blood vessel density, functionality, invasiveness of tumors into the surrounding tissues, and metastasis to the lymph node and lung were significantly increased in these tumors. Neutralizing the interactions of CXCL12/CXCR4 in vivo with CXCR4 specific antibodies inhibited the CXCR4‐dependent tumor growth and vascularization. In vitro, CXCL12 induced the proliferation and VEGF secretion but not migration of PC3 and 22Rv1 cells overexpressing CXCR4. Similar effects of CXCR4 overexpression on tumor growth in vivo were also noted in two breast cancer lines, suggesting that the observed effect of CXCR4 is not unique to prostate tumor cells. Thus high levels of the chemokine receptor CXCR4 induce a more aggressive phenotype in prostate cancer cells and identify CXCR4 as a potential therapeutic target in advanced cases of metastatic prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
Self-citationUse of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
Taichman, R. S., Cooper, C. R., Keller, E. T., Pienta, K. J., Taichman, N. S., & McCauley, L. K. (2002) · PubMed · Cited by 1,108
Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation
Stork, P. J. S., & Schmitt, J. M. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02294-8 · Cited by 897
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870 · cited 3×
“(33) on clear cell renal carcinoma, this study and the work by Sun YX.”
BackgroundInfluentialMolecular cloning and structure of a pre-B-cell growth-stimulating factor.
Nagasawa, T., Kikutani, H., & Kishimoto, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2305 · Cited by 803
Structure and Chromosomal Localization of the Human Stromal Cell-Derived Factor 1 (SDF1) Gene
Shirozu, M., Nakano, T., Inazawa, J., Tashiro, K., Tada, H., Shinohara, T., & Honjo, T. (1995) · Genomics · doi:10.1006/geno.1995.1180 · Cited by 624
Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W., & Groopman, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23169 · Cited by 613
A new human prostate carcinoma cell line, 22Rv1
Sramkoski, R. M., Pretlow, T. G., Giaconia, J. M., Pretlow, T. P., Schwartz, S., Sy, M.-S., Marengo, S. R., Rhim, J. S., Zhang, D., & Jacobberger, J. W. (1999) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-999-0115-4 · Cited by 591
Ponomaryov, T., Peled, A., Petit, I., Taichman, R. S., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Magerus, A., Caruz, A., Fujii, N., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10329 · Cited by 584
Self-citationPeled, A., Grabovsky, V., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Petit, I., Ben-Hur, H., Lapidot, T., & Alon, R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7615 · Cited by 549
Self-citationMultiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 471
Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
Sun, Y., Wang, J., Shelburne, C. E., Lopatin, D. E., Chinnaiyan, A. M., Rubin, M. A., Pienta, K. J., & Taichman, R. S. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10522 · Cited by 443
Bachelder, R. E., Wendt, M. A., & Mercurio, A. M. (2002) · PubMed · Cited by 424
Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., et al. (2000) · PubMed · Cited by 424
Chemokines and the Molecular Basis of Cancer Metastasis
Murphy, P. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109133451113 · Cited by 415
Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., & Ben-Baruch, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4747 · Cited by 409
Use of Reporter Genes for Optical Measurements of Neoplastic Disease In Vivo
Contag, C. H., Jenkins, D., Contag, P. R., & Negrin, R. S. (2000) · Neoplasia · doi:10.1038/sj.neo.7900079 · Cited by 363
Salvucci, O., Yao, L., Villalba, S., Sajewicz, A., Pittaluga, S., & Tosato, G. (2002) · Blood · doi:10.1182/blood.v99.8.2703 · Cited by 347
Epithelial cancer cell migration: a role for chemokine receptors?
Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., & Balkwill, F. R. (2001) · PubMed · Cited by 337
Barbero, S., Bonavia, R., Bajetto, A., Porcile, C., Pirani, P., Ravetti, J. L., Zona, G., Spaziante, R., Florio, T., & Schettini, G. (2003) · PubMed · Cited by 336
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth, J. A., Harb, J. F., Barroso, U., He, Z., Grignon, D. J., & Cher, M. L. (1999) · PubMed · Cited by 243
Kijowski, J., Baj‐Krzyworzeka, M., Majka, M., Reca, R., Marquez, L. A., Christofidou‐Solomidou, M., Janowska‐Wieczorek, A., & Ratajczak, M. Z. (2001) · STEM CELLS · doi:10.1634/stemcells.19-5-453 · Cited by 224
Lapidot, T. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03577.x · Cited by 196
Suzuki, Y., Rahman, M., & Mitsuya, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3064 · Cited by 176
Sehgal, A., Keener, C. L., Boynton, A. L., Warrick, J., & Murphy, G. P. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199810)69:2<99::aid-jso10>3.0.co;2-m · Cited by 158
Imaging Transgene Expression in Live Animals
Honigman, A., Zeira, E., Ohana, P., Abramovitz, R., Tavor, E., Bar, I., Zilberman, Y., Rabinovsky, R., Gazit, D., Joseph, A., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0437 · Cited by 154
Self-citationShen, W., Bendall, L. J., Gottlieb, D. J., & Bradstock, K. F. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00741-x · Cited by 141
Cashman, J. D., Clark‐Lewis, I., Eaves, A. C., & Eaves, C. J. (2002) · Blood · doi:10.1182/blood.v99.3.792 · Cited by 139
The role of chemoattraction in cancer metastases
Moore, M. A. S. (2001) · BioEssays · doi:10.1002/bies.1095 · Cited by 138
Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites.
Milliken, D., Scotton, C. J., Raju, S., Balkwill, F. R., & Wilson, J. L. (2002) · PubMed · Cited by 136
Beider, K., Nagler, A., Wald, O., Franitza, S., Dagan‐Berger, M., Wald, H., Giladi, H., Brocke, S., Hanna, J. H., Mandelboim, O., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3293 · Cited by 132
Self-citationAbramovitch, R., Dafni, H., Smouha, E., Benjamin, L. E., & Neeman, M. (1999) · PubMed · Cited by 121
Self-citationSDF-1 and CXCR4 in normal and malignant hematopoiesis.
Juarez, J. G., & Bendall, L. J. (2004) · PubMed · doi:10.14670/hh-19.299 · Cited by 96
Peled, A., Hardan, I., Trakhtenbrot, L., Gur, E., Magid, M., Darash‐Yahana, M., Cohen, N., Grabovsky, V., Franitza, S., Kollet, Ó., et al. (2002) · Stem Cells · doi:10.1634/stemcells.20-3-259 · Cited by 89
Self-citationNeuhaus, T., Stier, S., Totzke, G., Grünewald, E., Fronhoffs, S., Sachinidis, A., Vetter, H., & Ko, Y. D. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00262.x · Cited by 86
Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging
Abramovitch, R., Frenkiel‐Krispin, D., & Neeman, M. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910390519 · Cited by 82
Self-citationThe cellular and molecular basis of prostate cancer
Foster, Cornford, Forsyth, Djamgoz, & Ke (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00954.x · Cited by 70
Kanda, S., Mochizuki, Y., & Kanetake, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204771200 · Cited by 64
Bernards, R. (2003) · Nature · doi:10.1038/425247a · Cited by 55
Minamiguchi, H., Kimura, T., Urata, Y., Miyazaki, H., Bamba, T., Abe, T., & Sonoda, Y. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03068.x · Cited by 37
Cited by
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.49 · Cited by 2,206
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Cancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Côté, D., Means, T. K., Luster, A. D., Scadden, D. T., & Lin, C. P. (2005) · Nature · doi:10.1038/nature03703 · Cited by 878
Metadata
- Authors
- Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., & Peled, A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-06-04
- Volume
- 18
- Issue
- 11
- Pages
- 1240-1242
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2134068241
- Cited by
- 421
- References
- 43
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.